Skip to main content

Nurix Therapeutics, Inc.

NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001549595

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Nurix Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
3 insiders, $1.40M in total
Insiders trading
3
Net value
−$1.40M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Nurix Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Nurix Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Ring ChristineChief Legal Officer9,110Sep 2, 202618
Hansen GwennChief Scientific Officer117,227Sep 1, 202611
van Houte HansChief Financial Officer40,166Aug 4, 20268
Gregory Julia PDirector10,750May 15, 20261
Reinsdorf Judith ADirector–May 15, 20261
Silva Paul MDirector–May 15, 20261
Baynes Roy D.Director–May 15, 20261
Kapur AnilDirector–May 15, 20261
Lacey David L.Director–May 15, 20261
Dansey Roger DDirector–May 15, 20262
Saltzman Edward CDirector–May 15, 20261
Sands Arthur TPresident, CEO–Feb 10, 20261
Kunkel Lori AnneDirector0May 19, 20250
Wolff StefaniEVP and COO6,113May 2, 20230
Siegall Clay BDirector–May 6, 20220
Beaurang PierreChief Business Officer4,330Aug 11, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 2, 2026 (view filing)7:42 PM ETSep 2Same dayRing ChristineChief Legal OfficerSSale−5.79K$25.76−$149.1K−38.8%9.11K after2 lots10b5-1
Sep 1, 2026 (view filing)5:19 PM ETSep 1Same dayHansen GwennChief Scientific OfficerSSale−1.45K$25.47−$37.0K−1.2%117.2K after10b5-1
Aug 5, 2026 (view filing)6:59 PM ETAug 5Same dayHansen GwennChief Scientific OfficerSSale−4.36K$25.00−$108.9K−3.6%117.2K after10b5-1
Aug 5, 2026 (view filing)6:39 AM ETAug 41 dayHansen GwennChief Scientific OfficerSSale−4.11K$24.36−$100.1K−3.4%117.2K after2 lots10b5-1
Aug 4, 2026 (view filing)9:41 PM ETAug 4Same dayvan Houte HansChief Financial OfficerSSale−4.76K$24.36−$116.0K−10.6%40.2K after2 lots10b5-1
Aug 3, 2026 (view filing)5:51 PM ETAug 3Same dayRing ChristineChief Legal OfficerSSale−16.6K$23.05−$382.4K−64.6%9.11K after10b5-1
Jul 30, 2026 (view filing)5:58 PM ETJul 30Same dayvan Houte HansChief Financial OfficerSSale−2.85K$23.38−$66.5K−6.0%44.9K after
Jul 30, 2026 (view filing)5:56 PM ETJul 30Same dayRing ChristineChief Legal OfficerSSale−3.85K$23.38−$90.0K−16.2%19.9K after
Jul 30, 2026 (view filing)5:50 PM ETJul 30Same dayHansen GwennChief Scientific OfficerSSale−3.85K$23.38−$90.0K−3.1%121.3K after
Jul 2, 2026 (view filing)6:02 PM ETJul 2Same dayRing ChristineChief Legal OfficerSSale−11.0K$23.56−$259.4K−44.8%13.6K after10b5-1
Jun 25, 2026 (view filing)Jun 25Same dayRing ChristineChief Legal OfficerSSale−28.9K$20.06−$580.4K−68.1%13.6K after10b5-1
Jun 25, 2026 (view filing)Jun 25Same dayHansen GwennChief Scientific OfficerSSale−5.39K$20.00−$107.9K−4.5%115.0K after10b5-1
Jun 2, 2026 (view filing)Jun 2Same dayRing ChristineChief Legal OfficerSSale−8.15K$16.60−$135.3K−37.5%13.6K after10b5-1
May 5, 2026 (view filing)May 5Same dayvan Houte HansChief Financial OfficerSSale−14.1K$16.60−$233.4K−27.2%37.6K after2 lots10b5-1
May 4, 2026 (view filing)May 4Same dayRing ChristineChief Legal OfficerSSale−8.15K$16.96−$138.2K−30.8%18.3K after10b5-1
May 1, 2026 (view filing)May 1Same dayRing ChristineChief Legal OfficerSSale−5.39K$16.76−$90.4K−16.9%26.5K after10b5-1
Apr 30, 2026 (view filing)Apr 30Same dayvan Houte HansChief Financial OfficerSSale−2.39K$16.65−$39.8K−4.4%51.6K after
Apr 30, 2026 (view filing)Apr 30Same dayRing ChristineChief Legal OfficerSSale−3.21K$16.65−$53.5K−9.2%31.8K after
Apr 30, 2026 (view filing)Apr 30Same dayHansen GwennChief Scientific OfficerSSale−3.21K$16.65−$53.5K−2.6%120.4K after
Apr 2, 2026 (view filing)Apr 2Same dayRing ChristineChief Legal OfficerSSale−8.15K$15.24−$124.2K−23.5%26.5K after10b5-1
Mar 2, 2026 (view filing)Mar 2Same dayRing ChristineChief Legal OfficerSSale−8.15K$15.44−$125.8K−19.1%34.6K after10b5-1
Feb 9, 2026 (view filing)Feb 9Same dayRing ChristineChief Legal OfficerSSale−14.3K$16.66−$237.6K−25.0%42.7K after10b5-1
Jan 30, 2026 (view filing)Jan 30Same dayvan Houte HansChief Financial OfficerSSale−3.66K$16.60−$60.8K−7.5%45.4K after2 lots
Jan 30, 2026 (view filing)Jan 30Same dayRing ChristineChief Legal OfficerSSale−4.42K$16.60−$73.4K−7.2%57.0K after2 lots
Jan 30, 2026 (view filing)Jan 30Same dayHansen GwennChief Scientific OfficerSSale−4.89K$16.60−$81.2K−5.5%83.7K after2 lots
Jan 20, 2026 (view filing)Jan 20Same dayRing ChristineChief Legal OfficerSSale−3.76K$18.42−$69.3K−6.9%50.9K after10b5-1
Dec 18, 2025 (view filing)Dec 18Same dayRing ChristineChief Legal OfficerSSale−3.76K$17.91−$67.3K−6.9%50.9K after2 lots10b5-1
Nov 24, 2025 (view filing)Nov 24Same dayRing ChristineChief Legal OfficerSSale−37.6K$17.07−$641.8K−42.5%50.9K after10b5-1
Nov 3, 2025 (view filing)Nov 3Same dayvan Houte HansChief Financial OfficerSSale−6.28K$12.56−$78.9K−14.3%37.6K after10b5-1
Oct 30, 2025 (view filing)Oct 30Same dayvan Houte HansChief Financial OfficerSSale−3.13K$12.80−$40.1K−6.7%43.9K after
Oct 30, 2025 (view filing)Oct 30Same dayRing ChristineChief Legal OfficerSSale−3.64K$12.80−$46.6K−6.7%50.9K after
Oct 30, 2025 (view filing)Oct 30Same dayHansen GwennChief Scientific OfficerSSale−4.09K$12.80−$52.3K−5.1%76.8K after
Aug 1, 2025 (view filing)Aug 1Same dayvan Houte HansChief Financial OfficerSSale−5.40K$11.03−$59.6K−13.2%35.5K after10b5-1
Jul 30, 2025 (view filing)Jul 30Same dayvan Houte HansChief Financial OfficerSSale−4.30K$12.01−$51.7K−9.5%40.9K after
Jul 30, 2025 (view filing)Jul 30Same dayRing ChristineChief Legal OfficerSSale−3.84K$12.01−$46.1K−8.0%44.0K after
Jul 30, 2025 (view filing)Jul 30Same dayHansen GwennChief Scientific OfficerSSale−4.31K$12.01−$51.7K−5.9%69.0K after
May 2, 2025 (view filing)May 2Same dayvan Houte HansChief Financial OfficerSSale−6.20K$11.33−$70.2K−15.5%33.7K after10b5-1
Apr 30, 2025 (view filing)Apr 30Same dayHansen GwennChief Scientific OfficerSSale−3.38K$11.50−$38.8K−5.2%61.5K after
Apr 30, 2025 (view filing)Apr 30Same dayRing ChristineChief Legal OfficerSSale−2.89K$11.50−$33.3K−7.2%37.3K after
Apr 30, 2025 (view filing)Apr 30Same dayvan Houte HansChief Financial OfficerSSale−2.44K$11.50−$28.0K−5.8%39.9K after
Mar 3, 2025 (view filing)Mar 3Same dayvan Houte HansChief Financial OfficerSSale−5.83K$14.49−$84.4K−14.7%33.7K after2 lots10b5-1
Feb 3, 2025 (view filing)Jan 313 daysRing ChristineChief Legal OfficerSSale−5.76K$19.95−$114.9K−15.0%32.5K after2 lots10b5-1
Jan 30, 2025 (view filing)Jan 30Same dayRing ChristineChief Legal OfficerSSale−3.22K$19.86−$63.9K−9.0%32.5K after2 lots
Jan 30, 2025 (view filing)Jan 30Same dayHansen GwennChief Scientific OfficerSSale−3.69K$19.86−$73.3K−6.2%55.9K after2 lots
Jan 30, 2025 (view filing)Jan 30Same dayvan Houte HansChief Financial OfficerSSale−2.81K$19.86−$55.8K−6.6%39.5K after2 lots
Jan 2, 2025 (view filing)Jan 2Same dayRing ChristineChief Legal OfficerSSale−5.76K$19.50−$112.3K−17.0%28.1K after10b5-1
Dec 2, 2024 (view filing)Dec 2Same dayRing ChristineChief Legal OfficerSSale−5.76K$21.73−$125.2K−17.0%28.1K after10b5-1
Nov 4, 2024 (view filing)Nov 4Same dayRing ChristineChief Legal OfficerSSale−3.29K$25.00−$82.3K−10.5%28.1K after10b5-1
Nov 1, 2024 (view filing)Nov 1Same dayRing ChristineChief Legal OfficerSSale−5.76K$24.28−$139.9K−17.0%28.1K after10b5-1
Nov 1, 2024 (view filing)Nov 1Same dayvan Houte HansChief Financial OfficerSSale−3.55K$24.28−$86.1K−9.5%33.7K after10b5-1